Target intelligence / Profile preview

Stress-induced self-antigens

01

Overview

"Stress-induced self-antigens" describes a biological phenomenon where the body's own proteins become antigenic under conditions of cellular stress (e.g., infection, malignancy, hypoxia, damage). These molecules are typically not recognized as foreign but undergo upregulation, conformational changes, or altered localization, making them visible to the immune system. Examples include NKG2D ligands (MICA, MICB, ULBP proteins) involved in NK cell killing, and ribonucleoprotein complexes like Ro/SSA and La/SSB, or chaperones like calreticulin and Grp78/BiP, which are implicated in autoimmune diseases. This concept is not a single, well-defined molecular target for drug development, but rather a heterogeneous collection of molecules and mechanisms. Understanding this phenomenon is clinically relevant to cancer immunosurveillance and autoimmune disease pathogenesis, but therapeutic interventions would typically target specific antigens (e.g., NKG2D ligands) or their recognition pathways rather than the broad category of "stress-induced self-antigens".

02

Biological functions

Cellular molecules that become antigenic under stress conditions such as infection, malignant transformation, hypoxia, or cellular damage.Upregulated or undergo conformational changes under cellular stress, rendering them antigenic.Trigger immune responses (e.g., NK cell activation via NKG2D receptor binding).Contribute to autoimmune disease pathogenesis.
03

Disease associations

Cancer immunosurveillance (NK cell-mediated tumor recognition)Autoimmune disease pathogenesis (e.g., Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis, Primary Sjögren's Syndrome)Stress-induced immune dysregulationDepression-like behaviors

Beyond the preview

Go deeper on Stress-induced self-antigens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stress-induced self-antigens.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call